These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2043741)

  • 1. Antide-induced suppression of pituitary gonadotropin and ovarian steroid secretion in cynomolgus monkeys: premature luteolysis and prolonged inhibition of folliculogenesis following single treatment.
    Gordon K; Williams RF; Danforth DR; Hodgen GD
    Biol Reprod; 1991 Apr; 44(4):701-6. PubMed ID: 2043741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of ovarian estradiol secretion by a single injection of antide in cynomolgus monkeys during the early follicular phase: immediate, sustained, and reversible actions.
    Gordon K; Williams RF; Danforth DR; Conn PM; Hutchison JS; Hodgen GD
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1262-8. PubMed ID: 1955507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys.
    Molskness TA; Woodruff TK; Hess DL; Dahl KD; Stouffer RL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4002-6. PubMed ID: 8923851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of late follicular phase administration of antide on ovulation and inhibin secretion in macaques.
    Fraser HM; Lunn SF; Cowen GM; Smith KB; Conn PM
    Contraception; 1991 Dec; 44(6):667-76. PubMed ID: 1773623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of pituitary gonadotropin secretion by the gonadotropin-releasing hormone antagonist antide. II. Development of an in vitro bioassay for characterization of pharmacokinetics and pharmacodynamics of antide in circulation.
    Danforth DR; Williams RF; Gordon K; Leal JA; Hodgen GD
    Endocrinology; 1991 Apr; 128(4):2041-4. PubMed ID: 1900785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
    Fraser HM; Nestor JJ; Vickery BH
    Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Titrating luteinizing hormone replacement to sustain the structure and function of the corpus luteum after gonadotropin-releasing hormone antagonist treatment in rhesus monkeys.
    Duffy DM; Stewart DR; Stouffer RL
    J Clin Endocrinol Metab; 1999 Jan; 84(1):342-9. PubMed ID: 9920105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended presence of antide (Nal-Lys GnRH antagonist) in circulation: prolonged duration of gonadotropin inhibition may derive from antide binding to serum proteins.
    Danforth DR; Gordon K; Leal JA; Williams RF; Hodgen GD
    J Clin Endocrinol Metab; 1990 Feb; 70(2):554-6. PubMed ID: 2298867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen induces premature luteal regression in rhesus monkeys during spontaneous menstrual cycles, but not in cycles driven by exogenous gonadotropin-releasing hormone.
    Hutchison JS; Kubik CJ; Nelson PB; Zeleznik AJ
    Endocrinology; 1987 Aug; 121(2):466-74. PubMed ID: 3297646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel regimen of gonadotropin-releasing hormone (GnRH) antagonist plus pulsatile GnRH: controlled restoration of gonadotropin secretion and ovulation induction.
    Gordon K; Williams RF; Danforth DR; Hodgen GD
    Fertil Steril; 1990 Dec; 54(6):1140-5. PubMed ID: 2245840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human follicle-stimulating hormone stimulates multiple follicular growth, but minimal estrogen production in gonadotropin-releasing hormone antagonist-treated monkeys: examining the role of luteinizing hormone in follicular development and steroidogenesis.
    Karnitis VJ; Townson DH; Friedman CI; Danforth DR
    J Clin Endocrinol Metab; 1994 Jul; 79(1):91-7. PubMed ID: 8027261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human recombinant activin-A alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis, during the menstrual cycle in rhesus monkeys.
    Stouffer RL; Woodruff TK; Dahl KD; Hess DL; Mather JP; Molskness TA
    J Clin Endocrinol Metab; 1993 Jul; 77(1):241-8. PubMed ID: 8325947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of pituitary gonadotropin secretion by the gonadotropin-releasing hormone antagonist antide. I. In vitro studies on mechanism of action.
    Danforth DR; Williams RF; Gordon K; Hodgen GD
    Endocrinology; 1991 Apr; 128(4):2036-40. PubMed ID: 1900784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short term suppression of follicular recruitment and spontaneous ovulation in the cat using levonorgestrel versus a GnRH antagonist.
    Pelican KM; Brown JL; Wildt DE; Ottinger MA; Howard JG
    Gen Comp Endocrinol; 2005 Nov; 144(2):110-21. PubMed ID: 15979618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follicular atresia and infertility in rats treated with a gonadotropin-releasing hormone antagonist.
    Sharpe KL; Bertero MC; Lyon BP; Muse KN; Vernon MW
    Endocrinology; 1990 Jul; 127(1):25-31. PubMed ID: 2113868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing studies on multiple dose effects of antide (Nal-Lys) GnRH antagonist in ovariectomized monkeys.
    Leal JA; Gordon K; Williams RF; Danforth DR; Roh SI; Hodgen GD
    Contraception; 1989 Nov; 40(5):623-33. PubMed ID: 2515029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable tolerance of the developing follicle and corpus luteum to gonadotropin-releasing hormone antagonist-induced gonadotropin withdrawal in the human.
    Hall JE; Bhatta N; Adams JM; Rivier JE; Vale WW; Crowley WF
    J Clin Endocrinol Metab; 1991 May; 72(5):993-1000. PubMed ID: 1902489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding kinetics of the long-acting gonadotropin-releasing hormone (GnRH) antagonist antide to rat pituitary GnRH receptors.
    Li SL; Vuagnat B; Gruaz NM; Eshkol A; Sizonenko PC; Aubert ML
    Endocrinology; 1994 Jul; 135(1):45-52. PubMed ID: 8013383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress and the menstrual cycle: relevance of cycle quality in the short- and long-term response to a 5-day endotoxin challenge during the follicular phase in the rhesus monkey.
    Xiao E; Xia-Zhang L; Barth A; Zhu J; Ferin M
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2454-60. PubMed ID: 9661628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.